The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2023 Teaching Health Center Graduate Medical Education (THCGME) Program. The THCGME Program provides funding to support the training of residents in primary care residency training programs in community-based ambulatory patient care centers. Payments will be made for the following:
(1) expansion awards to support an increased number of resident Full-Time Equivalent (FTE) positions at existing HRSA THCGME Programs, and
(2) new awards to support new resident FTE positions at new Teaching Health Centers (THCs). New THCs are applicants that have never received payment under the HRSA THCGME Program for the applicable residency program.
Application Due Date: October 18, 2022
An eligible entity is a community-based ambulatory patient care center that sponsors an accredited primary care residency program in one of the following specialties/disciplines: • Family Medicine • Internal Medicine • Pediatrics • Internal Medicine-Pediatrics • Obstetrics and Gynecology • Psychiatry • General Dentistry • Pediatric Dentistry • Geriatrics
NOTE: Multiple applications from an eligible community-based entity or GME consortium with the same DUNS number or Unique Entity Identifier (UEI) are allowable if the applications seek funding for separate and distinct residency programs. Entities seeking THCGME funding to support multiple residency programs MUST submit a separate application for each individual residency program. If an entity is submitting multiple applications for different residency programs, please include a unique name for each training program in the project abstract to differentiate between applications.
HRSA expects approximately $18,400,000 to be available to fund approximately 28 recipients. The period of performance is July 1, 2023 through June 30, 2027 (4 years). Funding beyond the first year is subject to the availability of appropriated funds for the THCGME Program in subsequent fiscal years, satisfactory progress and a decision that continued funding is in the best interest of the Federal Government.
The FY 2023 THCGME Program payment is formula-based and provides a payment inclusive of both DME and IME support. The final payment methodology for the THCGME Program has not yet been established. The FY 2023 interim payment rate will be $160,000 per resident FTE. In subsequent fiscal years, the payment rate may change due to available appropriations and/or changes in payment methodology.